nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—CLCNKA—head—Parkinson's disease	0.0239	0.0766	CbGeAlD
Niflumic Acid—CLCNKA—cerebellum—Parkinson's disease	0.0213	0.0683	CbGeAlD
Niflumic Acid—PLA2G1B—cardiovascular system—Parkinson's disease	0.0139	0.0447	CbGeAlD
Niflumic Acid—SLC16A7—forebrain—Parkinson's disease	0.0139	0.0445	CbGeAlD
Niflumic Acid—SLC16A7—cardiovascular system—Parkinson's disease	0.0117	0.0376	CbGeAlD
Niflumic Acid—SLC16A7—medulla oblongata—Parkinson's disease	0.01	0.0322	CbGeAlD
Niflumic Acid—PLA2G1B—head—Parkinson's disease	0.00944	0.0303	CbGeAlD
Niflumic Acid—SLC16A7—midbrain—Parkinson's disease	0.00917	0.0294	CbGeAlD
Niflumic Acid—PLA2G1B—nervous system—Parkinson's disease	0.00895	0.0287	CbGeAlD
Niflumic Acid—PLA2G1B—central nervous system—Parkinson's disease	0.00862	0.0276	CbGeAlD
Niflumic Acid—PLA2G4A—cardiovascular system—Parkinson's disease	0.00849	0.0272	CbGeAlD
Niflumic Acid—SLC16A7—head—Parkinson's disease	0.00795	0.0255	CbGeAlD
Niflumic Acid—SLC16A7—nervous system—Parkinson's disease	0.00754	0.0242	CbGeAlD
Niflumic Acid—SLC16A1—cardiovascular system—Parkinson's disease	0.00747	0.024	CbGeAlD
Niflumic Acid—SLC16A7—central nervous system—Parkinson's disease	0.00726	0.0233	CbGeAlD
Niflumic Acid—PLA2G4A—medulla oblongata—Parkinson's disease	0.00725	0.0233	CbGeAlD
Niflumic Acid—SLC16A7—cerebellum—Parkinson's disease	0.00709	0.0227	CbGeAlD
Niflumic Acid—PLA2G1B—brain—Parkinson's disease	0.00684	0.0219	CbGeAlD
Niflumic Acid—PLA2G4A—midbrain—Parkinson's disease	0.00663	0.0213	CbGeAlD
Niflumic Acid—PLA2G4A—spinal cord—Parkinson's disease	0.00647	0.0207	CbGeAlD
Niflumic Acid—SLC16A1—medulla oblongata—Parkinson's disease	0.00639	0.0205	CbGeAlD
Niflumic Acid—SLC16A1—midbrain—Parkinson's disease	0.00584	0.0187	CbGeAlD
Niflumic Acid—SLC16A7—brain—Parkinson's disease	0.00576	0.0185	CbGeAlD
Niflumic Acid—SLC16A1—spinal cord—Parkinson's disease	0.00569	0.0183	CbGeAlD
Niflumic Acid—PLA2G4A—nervous system—Parkinson's disease	0.00545	0.0175	CbGeAlD
Niflumic Acid—PLA2G4A—central nervous system—Parkinson's disease	0.00525	0.0168	CbGeAlD
Niflumic Acid—SLC16A1—head—Parkinson's disease	0.00506	0.0162	CbGeAlD
Niflumic Acid—SLC16A1—nervous system—Parkinson's disease	0.0048	0.0154	CbGeAlD
Niflumic Acid—SLC16A1—central nervous system—Parkinson's disease	0.00462	0.0148	CbGeAlD
Niflumic Acid—SLC16A1—cerebellum—Parkinson's disease	0.00452	0.0145	CbGeAlD
Niflumic Acid—PTGS2—embryo—Parkinson's disease	0.00428	0.0137	CbGeAlD
Niflumic Acid—PLA2G4A—brain—Parkinson's disease	0.00417	0.0134	CbGeAlD
Niflumic Acid—PTGS1—forebrain—Parkinson's disease	0.00396	0.0127	CbGeAlD
Niflumic Acid—PTGS2—forebrain—Parkinson's disease	0.00379	0.0122	CbGeAlD
Niflumic Acid—SLC16A1—brain—Parkinson's disease	0.00367	0.0118	CbGeAlD
Niflumic Acid—PTGS1—cardiovascular system—Parkinson's disease	0.00335	0.0107	CbGeAlD
Niflumic Acid—PTGS2—cardiovascular system—Parkinson's disease	0.0032	0.0103	CbGeAlD
Niflumic Acid—PTGS2—medulla oblongata—Parkinson's disease	0.00274	0.00878	CbGeAlD
Niflumic Acid—PTGS1—spinal cord—Parkinson's disease	0.00255	0.00819	CbGeAlD
Niflumic Acid—PTGS2—midbrain—Parkinson's disease	0.0025	0.00802	CbGeAlD
Niflumic Acid—PTGS2—spinal cord—Parkinson's disease	0.00244	0.00783	CbGeAlD
Niflumic Acid—PTGS1—head—Parkinson's disease	0.00227	0.00728	CbGeAlD
Niflumic Acid—PTGS2—head—Parkinson's disease	0.00217	0.00696	CbGeAlD
Niflumic Acid—PTGS1—nervous system—Parkinson's disease	0.00215	0.0069	CbGeAlD
Niflumic Acid—PTGS1—central nervous system—Parkinson's disease	0.00207	0.00664	CbGeAlD
Niflumic Acid—PTGS2—nervous system—Parkinson's disease	0.00206	0.0066	CbGeAlD
Niflumic Acid—PTGS2—central nervous system—Parkinson's disease	0.00198	0.00635	CbGeAlD
Niflumic Acid—PTGS2—cerebellum—Parkinson's disease	0.00194	0.00621	CbGeAlD
Niflumic Acid—PTGS1—brain—Parkinson's disease	0.00165	0.00527	CbGeAlD
Niflumic Acid—PTGS2—brain—Parkinson's disease	0.00157	0.00504	CbGeAlD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PENK—Parkinson's disease	0.000554	0.000805	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IGF2—Parkinson's disease	0.000552	0.000802	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TALDO1—Parkinson's disease	0.000531	0.000771	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—OMD—Parkinson's disease	0.000531	0.000771	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Parkinson's disease	0.000527	0.000765	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000522	0.000759	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—HGF—Parkinson's disease	0.000521	0.000757	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP2D6—Parkinson's disease	0.000521	0.000757	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—DBH—Parkinson's disease	0.000516	0.00075	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—FBP1—Parkinson's disease	0.000516	0.00075	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GBA—Parkinson's disease	0.000516	0.00075	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CTGF—Parkinson's disease	0.000511	0.000743	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DGKQ—Parkinson's disease	0.000508	0.000738	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GPR37—Parkinson's disease	0.000508	0.000738	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PDYN—Parkinson's disease	0.000506	0.000736	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000504	0.000732	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NDUFB11—Parkinson's disease	0.000503	0.000731	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000496	0.000721	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000489	0.00071	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.000488	0.000709	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—DDC—Parkinson's disease	0.000487	0.000708	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000484	0.000703	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GCH1—Parkinson's disease	0.00048	0.000697	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP2E1—Parkinson's disease	0.000476	0.000692	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NQO1—Parkinson's disease	0.000471	0.000684	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—GRM5—Parkinson's disease	0.000471	0.000684	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—VPS35—Parkinson's disease	0.000469	0.000682	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000465	0.000675	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000464	0.000675	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—TH—Parkinson's disease	0.000464	0.000675	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000462	0.000672	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000462	0.000671	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MCCC1—Parkinson's disease	0.00046	0.000668	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ND3—Parkinson's disease	0.00046	0.000668	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTA4—Parkinson's disease	0.00046	0.000668	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SOD1—Parkinson's disease	0.000452	0.000656	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYCS—Parkinson's disease	0.000446	0.000648	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00044	0.00064	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MCCC1—Parkinson's disease	0.000436	0.000634	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000433	0.000629	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TALDO1—Parkinson's disease	0.000432	0.000628	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—OMD—Parkinson's disease	0.000432	0.000628	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ABL1—Parkinson's disease	0.000431	0.000626	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IGF2—Parkinson's disease	0.000429	0.000623	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GBA—Parkinson's disease	0.000428	0.000621	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DBH—Parkinson's disease	0.000428	0.000621	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—FBP1—Parkinson's disease	0.000428	0.000621	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000425	0.000617	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000422	0.000613	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PLA2G6—Parkinson's disease	0.000414	0.000602	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NDUFB11—Parkinson's disease	0.00041	0.000596	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MAOB—Parkinson's disease	0.00041	0.000596	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TALDO1—Parkinson's disease	0.00041	0.000596	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—OMD—Parkinson's disease	0.00041	0.000596	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RIT2—Parkinson's disease	0.000406	0.00059	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—HGF—Parkinson's disease	0.000405	0.000589	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.0004	0.000582	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—COMT—Parkinson's disease	0.000395	0.000574	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTP1—Parkinson's disease	0.000393	0.000571	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MAOA—Parkinson's disease	0.000392	0.000569	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GCH1—Parkinson's disease	0.000391	0.000568	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000388	0.000564	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—HMOX1—Parkinson's disease	0.000387	0.000563	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GRK5—Parkinson's disease	0.000385	0.000559	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—DDC—Parkinson's disease	0.000379	0.00055	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ABCB1—Parkinson's disease	0.000372	0.00054	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL1B—Parkinson's disease	0.000365	0.000531	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MCCC1—Parkinson's disease	0.000365	0.000531	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ND3—Parkinson's disease	0.000365	0.000531	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CASP3—Parkinson's disease	0.000364	0.000529	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTM1—Parkinson's disease	0.000361	0.000525	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTA4—Parkinson's disease	0.000358	0.00052	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000353	0.000513	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000353	0.000513	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GBA—Parkinson's disease	0.000349	0.000507	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DBH—Parkinson's disease	0.000349	0.000507	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—FBP1—Parkinson's disease	0.000349	0.000507	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000347	0.000505	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GPX1—Parkinson's disease	0.000346	0.000502	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GRM4—Parkinson's disease	0.000345	0.000501	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TALDO1—Parkinson's disease	0.000343	0.000499	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—OMD—Parkinson's disease	0.000343	0.000499	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—TAC1—Parkinson's disease	0.000342	0.000497	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000341	0.000495	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000336	0.000488	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—DRD1—Parkinson's disease	0.000335	0.000487	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000335	0.000487	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TAF1—Parkinson's disease	0.00033	0.00048	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FBP1—Parkinson's disease	0.00033	0.00048	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PENK—Parkinson's disease	0.000327	0.000475	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAG—Parkinson's disease	0.000327	0.000475	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NDUFB11—Parkinson's disease	0.000325	0.000473	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—DRD3—Parkinson's disease	0.000325	0.000472	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PLA2G6—Parkinson's disease	0.000322	0.000468	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—Parkinson's disease	0.000319	0.000464	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MAOB—Parkinson's disease	0.000319	0.000463	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DDC—Parkinson's disease	0.000314	0.000456	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GCH1—Parkinson's disease	0.00031	0.000451	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP2D6—Parkinson's disease	0.000305	0.000443	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000303	0.000441	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000303	0.000441	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDYN—Parkinson's disease	0.000299	0.000435	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CTGF—Parkinson's disease	0.000299	0.000435	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—APOE—Parkinson's disease	0.000297	0.000432	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTA4—Parkinson's disease	0.000296	0.000431	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR7—Parkinson's disease	0.000294	0.000427	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—DRD2—Parkinson's disease	0.000294	0.000427	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000293	0.000425	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GFAP—Parkinson's disease	0.000281	0.000409	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00028	0.000407	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP2E1—Parkinson's disease	0.000279	0.000405	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GRM5—Parkinson's disease	0.000278	0.000404	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DBH—Parkinson's disease	0.000277	0.000402	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—FBP1—Parkinson's disease	0.000277	0.000402	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GBA—Parkinson's disease	0.000277	0.000402	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NQO1—Parkinson's disease	0.000276	0.0004	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—TH—Parkinson's disease	0.000272	0.000395	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—Parkinson's disease	0.00027	0.000393	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PLA2G6—Parkinson's disease	0.000267	0.000388	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—Parkinson's disease	0.000265	0.000385	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MAOB—Parkinson's disease	0.000264	0.000384	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RPL6—Parkinson's disease	0.000264	0.000384	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SNCA—Parkinson's disease	0.000264	0.000384	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYCS—Parkinson's disease	0.000261	0.000379	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DDC—Parkinson's disease	0.000256	0.000372	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—INS—Parkinson's disease	0.000254	0.000369	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000251	0.000365	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000248	0.00036	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGF20—Parkinson's disease	0.000244	0.000354	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.000242	0.000351	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000239	0.000347	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP2D6—Parkinson's disease	0.000237	0.000344	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000236	0.000344	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EDN1—Parkinson's disease	0.000235	0.000342	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CTGF—Parkinson's disease	0.000233	0.000338	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—COMT—Parkinson's disease	0.000231	0.000336	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTP1—Parkinson's disease	0.00023	0.000334	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MAOA—Parkinson's disease	0.000229	0.000333	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000228	0.000331	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—HMOX1—Parkinson's disease	0.000227	0.000329	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—INSR—Parkinson's disease	0.000218	0.000317	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PLA2G6—Parkinson's disease	0.000218	0.000316	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ABCB1—Parkinson's disease	0.000218	0.000316	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP2E1—Parkinson's disease	0.000217	0.000315	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MAOB—Parkinson's disease	0.000215	0.000313	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NQO1—Parkinson's disease	0.000214	0.000311	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	0.000214	0.000311	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TH—Parkinson's disease	0.000211	0.000307	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTM1—Parkinson's disease	0.000211	0.000307	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGB—Parkinson's disease	0.000206	0.0003	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000206	0.000299	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR1A—Parkinson's disease	0.000205	0.000298	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000205	0.000298	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DDC—Parkinson's disease	0.000203	0.000295	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYCS—Parkinson's disease	0.000203	0.000295	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GPX1—Parkinson's disease	0.000202	0.000294	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TAC1—Parkinson's disease	0.000202	0.000294	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RPL23A—Parkinson's disease	0.0002	0.000291	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RPL14—Parkinson's disease	0.0002	0.000291	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DRD1—Parkinson's disease	0.000198	0.000288	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP2D6—Parkinson's disease	0.000196	0.000285	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CTGF—Parkinson's disease	0.000193	0.00028	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DRD3—Parkinson's disease	0.000192	0.000279	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTA4—Parkinson's disease	0.000192	0.000279	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000189	0.000275	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RPS8—Parkinson's disease	0.000187	0.000271	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FGF20—Parkinson's disease	0.000187	0.000271	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—Parkinson's disease	0.000187	0.000271	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.00018	0.000262	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP2E1—Parkinson's disease	0.00018	0.000261	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—COMT—Parkinson's disease	0.00018	0.000261	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000179	0.00026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTP1—Parkinson's disease	0.000179	0.00026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MAOA—Parkinson's disease	0.000178	0.000259	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NQO1—Parkinson's disease	0.000178	0.000258	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—HMOX1—Parkinson's disease	0.000176	0.000256	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TH—Parkinson's disease	0.000175	0.000254	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOE—Parkinson's disease	0.000174	0.000253	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DRD2—Parkinson's disease	0.000174	0.000252	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR7—Parkinson's disease	0.000174	0.000252	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PLA2G6—Parkinson's disease	0.000173	0.000251	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MAOB—Parkinson's disease	0.000171	0.000248	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ABCB1—Parkinson's disease	0.000169	0.000246	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYCS—Parkinson's disease	0.000168	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—Parkinson's disease	0.000164	0.000239	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000163	0.000236	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP2D6—Parkinson's disease	0.00016	0.000233	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GPX1—Parkinson's disease	0.000157	0.000229	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CTGF—Parkinson's disease	0.000157	0.000228	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—COMT—Parkinson's disease	0.000149	0.000216	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—INS—Parkinson's disease	0.000148	0.000216	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTP1—Parkinson's disease	0.000148	0.000215	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MAOA—Parkinson's disease	0.000148	0.000215	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP2E1—Parkinson's disease	0.000146	0.000213	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HMOX1—Parkinson's disease	0.000146	0.000212	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF2—Parkinson's disease	0.000145	0.000211	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—Parkinson's disease	0.000145	0.000211	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NQO1—Parkinson's disease	0.000145	0.00021	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TH—Parkinson's disease	0.000143	0.000207	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1R—Parkinson's disease	0.000141	0.000204	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ABCB1—Parkinson's disease	0.00014	0.000204	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDN1—Parkinson's disease	0.000139	0.000202	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ADRBK1—Parkinson's disease	0.000137	0.000199	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYCS—Parkinson's disease	0.000137	0.000199	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HSPA1A—Parkinson's disease	0.000136	0.000198	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—Parkinson's disease	0.000136	0.000198	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOE—Parkinson's disease	0.000135	0.000196	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GPX1—Parkinson's disease	0.00013	0.000189	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NGF—Parkinson's disease	0.000128	0.000186	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP2D6—Parkinson's disease	0.000127	0.000185	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CTGF—Parkinson's disease	0.000125	0.000181	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR2A—Parkinson's disease	0.000122	0.000177	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—COMT—Parkinson's disease	0.000121	0.000176	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTP1—Parkinson's disease	0.000121	0.000175	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MAOA—Parkinson's disease	0.00012	0.000175	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—Parkinson's disease	0.00012	0.000175	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HMOX1—Parkinson's disease	0.000119	0.000173	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP2E1—Parkinson's disease	0.000116	0.000169	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—INS—Parkinson's disease	0.000115	0.000168	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NQO1—Parkinson's disease	0.000115	0.000167	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ABCB1—Parkinson's disease	0.000114	0.000166	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TH—Parkinson's disease	0.000113	0.000165	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOE—Parkinson's disease	0.000113	0.000164	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOE—Parkinson's disease	0.000112	0.000163	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—Parkinson's disease	0.000111	0.000161	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYCS—Parkinson's disease	0.000109	0.000158	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GPX1—Parkinson's disease	0.000106	0.000154	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—Parkinson's disease	9.81e-05	0.000142	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—INS—Parkinson's disease	9.65e-05	0.00014	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—COMT—Parkinson's disease	9.63e-05	0.00014	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTP1—Parkinson's disease	9.58e-05	0.000139	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—INS—Parkinson's disease	9.57e-05	0.000139	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MAOA—Parkinson's disease	9.56e-05	0.000139	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMOX1—Parkinson's disease	9.45e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—Parkinson's disease	9.29e-05	0.000135	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOE—Parkinson's disease	9.13e-05	0.000133	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ABCB1—Parkinson's disease	9.07e-05	0.000132	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—Parkinson's disease	8.81e-05	0.000128	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOE—Parkinson's disease	8.65e-05	0.000126	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GPX1—Parkinson's disease	8.43e-05	0.000123	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—INS—Parkinson's disease	7.8e-05	0.000113	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—Parkinson's disease	7.78e-05	0.000113	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—INS—Parkinson's disease	7.39e-05	0.000107	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOE—Parkinson's disease	7.25e-05	0.000105	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CASP3—Parkinson's disease	7.19e-05	0.000104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—Parkinson's disease	7.14e-05	0.000104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAPK8—Parkinson's disease	6.61e-05	9.6e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—INS—Parkinson's disease	6.19e-05	9e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—Parkinson's disease	4.22e-05	6.13e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—Parkinson's disease	3.23e-05	4.69e-05	CbGpPWpGaD
